{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:06:02Z","timestamp":1790021162186,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1124\/dmd.123.001453","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T18:00:12Z","timestamp":1696010412000},"page":"1547-1550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Innovations, Opportunities, and Challenges for Predicting Alteration in Drug-Metabolizing Enzyme and Transporter Activity in Specific Populations"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5661-9011","authenticated-orcid":false,"given":"Paresh P.","family":"Chothe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9090-0912","authenticated-orcid":false,"given":"Bhagwat","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-0728","authenticated-orcid":false,"given":"Diane","family":"Ramsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Taskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.123.001453_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cpt.2907","article-title":"Intestinal Metabolism of Diclofenac by Polymorphic UGT2B17 Correlates with its Highly Variable Pharmacokinetics and Safety across Populations","volume":"114","author":"Ahire","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001453_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cpt.176","article-title":"Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group","volume":"98","author":"Brouwer","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001453_bib3","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1111\/bcp.14821","article-title":"Recent advances in the ontogeny of drug disposition","volume":"88","author":"Chapron","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.123.001453_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1021\/acs.chemrestox.5b00511","article-title":"Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and Development","volume":"29","author":"Cheng","year":"2016","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.123.001453_bib5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1124\/dmd.115.067801","article-title":"Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics","volume":"44","author":"Elmorsi","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001453_bib6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cpt.1115","article-title":"Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and\/or Toxicity of Drugs: A White Paper From the International Transporter Consortium","volume":"104","author":"Evers","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001453_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep4.1647","article-title":"Human Nonalcoholic Steatohepatitis on a Chip","volume":"5","author":"Freag","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1124\/dmd.123.001453_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/dmd.122.001038","article-title":"Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination","volume":"51","author":"Frost","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001453_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pharmtox.44.101802.121453","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"44","author":"Gandhi","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.123.001453_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/biomedicines11020384","article-title":"Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis","volume":"11","author":"Hayashi","year":"2023","journal-title":"Biomedicines"},{"key":"10.1124\/dmd.123.001453_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001453_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/clpt.1985.114","article-title":"Pregnancy-induced increase in metoprolol metabolism","volume":"37","author":"H\u00f6gstedt","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001453_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12967-018-1710-5","article-title":"Reviewing the role of healthy volunteer studies in drug development","volume":"16","author":"Karakunnel","year":"2018","journal-title":"J Transl Med"},{"key":"10.1124\/dmd.123.001453_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/psp4.12901","article-title":"Predicting changes in the pharmacokinetics of CYP3A-metabolized drugs in hepatic impairment and insights into factors driving these changes","volume":"12","author":"Ladumor","year":"2023","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/dmd.123.001453_bib15","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/cpt.2829","article-title":"Effect of Hepatic Impairment on OATP1B Activity: Quantitative Pharmacokinetic Analysis of Endogenous Biomarker and Substrate Drugs","volume":"113","author":"Lin","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001453_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40262-020-00977-w","article-title":"Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir","volume":"60","author":"Liu","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.123.001453_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/gerona\/glr118","article-title":"Drug metabolism in older people--a key consideration in achieving optimal outcomes with medicines","volume":"67","author":"McLachlan","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1124\/dmd.123.001453_bib18","doi-asserted-by":"crossref","first-page":"15168","DOI":"10.3390\/ijms232315168","article-title":"Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4\u03b2-Hydroxycholesterol\/Cholesterol Ratio","volume":"23","author":"Mlugu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1124\/dmd.123.001453_bib19","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/clpt.2008.59","article-title":"Emerging evidence of the impact of kidney disease on drug metabolism and transport","volume":"83","author":"Nolin","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001453_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/01.WNL.0000103286.47129.F8","article-title":"The impact of pregnancy and childbirth on the metabolism of lamotrigine","volume":"62","author":"Pennell","year":"2004","journal-title":"Neurology"},{"key":"10.1124\/dmd.123.001453_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cpt.1537","article-title":"Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper","volume":"106","author":"Prasad","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001453_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s12072-021-10237-z","article-title":"Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids","volume":"15","author":"Ramakrishna","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1124\/dmd.123.001453_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.726669","article-title":"Quantification of CYP3A and Drug Transporters Activity in Healthy Young, Healthy Elderly and Chronic Kidney Disease Elderly Patients by a Microdose Cocktail Approach","volume":"12","author":"Rattanacheeworn","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.123.001453_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","article-title":"The influence of sex on pharmacokinetics","volume":"42","author":"Schwartz","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.123.001453_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2174\/138920011796504527","article-title":"Age-related changes in pharmacokinetics","volume":"12","author":"Shi","year":"2011","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.123.001453_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.123.001453_bib27","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s11095-013-1129-x","article-title":"Disease, drug metabolism, and transporter interactions","volume":"30","author":"Staudinger","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.123.001453_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.05.010","article-title":"Effects of renal failure on drug transport and metabolism","volume":"109","author":"Sun","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.123.001453_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120904","article-title":"A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoids","volume":"275","author":"Teng","year":"2021","journal-title":"Biomaterials"},{"key":"10.1124\/dmd.123.001453_bib30","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.123.001453_bib31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cpt.1699","article-title":"Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease","volume":"107","author":"Vildhede","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001453_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40264-017-0635-x","article-title":"Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis","volume":"41","author":"Weersink","year":"2018","journal-title":"Drug Saf"},{"key":"10.1124\/dmd.123.001453_bib33","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7609.1000119","article-title":"Sex Differences in the Expression of Drug-Metabolizing and Transporter Genes in Human Liver","volume":"3","author":"Yang","year":"2012","journal-title":"J Drug Metab Toxicol"},{"key":"10.1124\/dmd.123.001453_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060368","article-title":"Gene expression variability in human hepatic drug metabolizing enzymes and transporters","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/dmd.123.001453_bib35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ki.2013.399","article-title":"Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport","volume":"85","author":"Yeung","year":"2014","journal-title":"Kidney Int"},{"key":"10.1124\/dmd.123.001453_bib36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/FTD.0000000000000724","article-title":"Pregnancy Alters CYP- and UGT-Mediated Metabolism of Buprenorphine","volume":"42","author":"Zhang","year":"2020","journal-title":"Ther Drug Monit"},{"key":"10.1124\/dmd.123.001453_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/03602532.2023.2202359","article-title":"The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice","volume":"55","author":"Zhu","year":"2023","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.123.001453_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13293-020-00308-5","article-title":"Sex differences in pharmacokinetics predict adverse drug reactions in women","volume":"11","author":"Zucker","year":"2020","journal-title":"Biol Sex Differ"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624011012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624011012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.123.001453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:06:24Z","timestamp":1739955984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624011012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0090955624011012"],"URL":"https:\/\/doi.org\/10.1124\/dmd.123.001453","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovations, Opportunities, and Challenges for Predicting Alteration in Drug-Metabolizing Enzyme and Transporter Activity in Specific Populations","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.123.001453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}